AVM
BOLD

Arch Venture Management’s Boundless Bio BOLD Stock Holding History

Arch Venture Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Buy
+2,694,095
New +$4.15M 0.61% 11

Other funds holding BOLD

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Arch Venture Management's BOLD Position: Q2 2026 in Review

Arch Venture Management opened a new position in Boundless Bio (BOLD) in Q2 2026: 2,694,095 shares worth $6.74M. The stake represents 0.61% of the portfolio and ranks #11 among its holdings.

34 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Arch Venture Management held 2,694,095 shares of Boundless Bio worth $6.74M as of Q2 2026.
  • Boundless Bio was a new Arch Venture Management position in Q2 2026.
  • Boundless Bio made up 0.61% of Arch Venture Management's portfolio in Q2 2026, its #11 holding.
  • 34 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Arch Venture Management's 13F filing for Q2 2026, filed 14 Aug 2026.